• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Apple Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    1/30/25 4:30:23 PM ET
    $AAPL
    Computer Manufacturing
    Technology
    Get the next $AAPL alert in real time by email
    aapl-20250130
    false000032019300003201932025-01-302025-01-300000320193us-gaap:CommonStockMember2025-01-302025-01-300000320193aapl:A0.000Notesdue2025Member2025-01-302025-01-300000320193aapl:A0.875NotesDue2025Member2025-01-302025-01-300000320193aapl:A1.625NotesDue2026Member2025-01-302025-01-300000320193aapl:A2.000NotesDue2027Member2025-01-302025-01-300000320193aapl:A1.375NotesDue2029Member2025-01-302025-01-300000320193aapl:A3.050NotesDue2029Member2025-01-302025-01-300000320193aapl:A0.500Notesdue2031Member2025-01-302025-01-300000320193aapl:A3.600NotesDue2042Member2025-01-302025-01-30

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
    January 30, 2025
    Date of Report (Date of earliest event reported)
    g325078g0426062022046a24.jpg
    Apple Inc.
    (Exact name of Registrant as specified in its charter)

    California 001-36743 94-2404110
    (State or other jurisdiction
    of incorporation)
     (Commission
    File Number)
     (I.R.S. Employer
    Identification No.)
    One Apple Park Way
    Cupertino, California 95014
    (Address of principal executive offices) (Zip Code)
    (408) 996-1010
    (Registrant’s telephone number, including area code)
    Not applicable
    (Former name or former address, if changed since last report.)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading symbol(s)Name of each exchange on which registered
    Common Stock, $0.00001 par value per shareAAPLThe Nasdaq Stock Market LLC
    0.000% Notes due 2025—The Nasdaq Stock Market LLC
    0.875% Notes due 2025—The Nasdaq Stock Market LLC
    1.625% Notes due 2026—The Nasdaq Stock Market LLC
    2.000% Notes due 2027—The Nasdaq Stock Market LLC
    1.375% Notes due 2029—The Nasdaq Stock Market LLC
    3.050% Notes due 2029—The Nasdaq Stock Market LLC
    0.500% Notes due 2031—The Nasdaq Stock Market LLC
    3.600% Notes due 2042—The Nasdaq Stock Market LLC
    Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 2.02    Results of Operations and Financial Condition.
    On January 30, 2025, Apple Inc. (“Apple”) issued a press release regarding Apple’s financial results for its first fiscal quarter ended December 28, 2024. A copy of Apple’s press release is attached hereto as Exhibit 99.1.
    The information contained in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
     
    Item 9.01    Financial Statements and Exhibits.
    (d)Exhibits.
    Exhibit
    Number
    Exhibit Description
    99.1
    Press release issued by Apple Inc. on January 30, 2025.
    104Inline XBRL for the cover page of this Current Report on Form 8-K.



    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date:January 30, 2025Apple Inc.
    By:/s/ Kevan Parekh
    Kevan Parekh
    Senior Vice President,
    Chief Financial Officer

    Get the next $AAPL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AAPL

    DatePrice TargetRatingAnalyst
    6/4/2025Buy → Hold
    Needham
    5/2/2025$290.00 → $275.00Buy
    TD Cowen
    5/2/2025$217.00Buy → Neutral
    Rosenblatt
    5/2/2025$170.62Hold → Underperform
    Jefferies
    5/2/2025$260.00 → $245.00Buy
    Monness Crespi & Hardt
    4/30/2025$197.00 → $173.00Underweight
    Barclays
    4/30/2025$230.00 → $215.00Hold
    Loop Capital
    4/29/2025$220.00 → $235.00Overweight
    Morgan Stanley
    More analyst ratings

    $AAPL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • September 17, 2024 - FDA Roundup: September 17, 2024

      For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

      9/17/24 2:34:22 PM ET
      $AAPL
      Computer Manufacturing
      Technology
    • September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

      For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

      9/12/24 10:58:17 AM ET
      $AAPL
      Computer Manufacturing
      Technology

    $AAPL
    SEC Filings

    See more
    • Apple Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Apple Inc. (0000320193) (Filer)

      5/12/25 4:30:28 PM ET
      $AAPL
      Computer Manufacturing
      Technology
    • SEC Form FWP filed by Apple Inc.

      FWP - Apple Inc. (0000320193) (Subject)

      5/5/25 8:58:13 PM ET
      $AAPL
      Computer Manufacturing
      Technology
    • SEC Form 10-Q filed by Apple Inc.

      10-Q - Apple Inc. (0000320193) (Filer)

      5/2/25 6:00:46 AM ET
      $AAPL
      Computer Manufacturing
      Technology